Blogroll
- Ben’s Stem Cell News
- Biosingularity
- Biotech Blog
- Cell WISE
- CellTherapyBlog
- CellTherapyNews
- Fierce Biotech
- Fredrick County, MD Biotech Community
- Hematopoiesis
- IN VIVO blog
- Life Sciences Chronicle
- List of Biotech Conferences
- My Biotech Life
- Partial Immortalization
- Stem Cell Patents
- The Niche
- The Stem Cell
- US PTO
- Venture Beat – Lifesciences
- Wired Blogs – Science
- WordPress.com
Cool Regenmed Jobs
- Biomaterials and Diabetes Scientists at Living Cell Technologies (New Zealand)
- Cell and Tissue Culture Technicians at Pharmacell (ex-US)
- Cell Culture, Bioprocess, Analytical, and Tissue Engineering positions open at Tengion
- Cell Process Development and Production Positions at Cognate Bioservices
- Cell Therapy Business Development Leader at Invitrogen
- Jobs at Geron: chemists, process and product development, cell biology, immunology, assay development, and quality positions
- Manufacturing Manager at Cognate Bioservices
- Process Dev, R&D, Quality and other jobs at Tigenix (Belgium and US)
- RegenMed Scientists and Research Associates at Athersys
- Research and Quality positions at Biomimetic Therapeutics
General Science
Local Biotech Gateways
Other Biotech Blogs
Patents
Archives
Catagory Cloud
adult stem cell Advanced Cell Technology Apptec Athersys BD Big Pharma Biomaterials Bioprocessing business models cardiac regeneration cell delivery Clinical Trials combination products Company Profiles Embyonic Stem Cells FDA Geron Innovation Intellectual Property Invitrogen JNJ Job search Joint Ventures Manufacturing Novocell Osiris Regenerative Medicine regulatory stem cells vascular regeneration
Category Archives: JNJ
The Developing Embyronic Stem Cell Clinical Landscape
ES cell biopsy from blastocyst. Continue reading
Posted in adult stem cell, Advanced Cell Technology, Athersys, Clinical Trials, Cytori, Embyonic Stem Cells, FDA, Geron, JNJ, Novocell, Osiris, Regenerative Medicine, spinal cord injury, stem cells
Tagged Clinical Trials, embryonic vs adult stem cell, embyryonic stem cell 2008, evolving clinical landscape, safety issues
Leave a comment
Tengion Pioneers Autologous Tissue Engineered Regenerative Medicine Products
You have to hand it to Tengion, they are trying to tackle one of the largest challenges I can think of: producing tissue engineered organs and tissues from a patients own cells in unrelated indications (bladder, blood vessel, and kidney). … Continue reading
Posted in autologous, Biomaterials, Bioprocessing, Clinical Trials, combination products, Company Profiles, JNJ, patient specific cell therapy, personalized medicine, Regenerative Medicine, Tengion, tissue engineered product, vascular regeneration
Tagged autologous therapies, company prifile, tissue engineering company
3 Comments
Consolidation Trends Within the Blossoming RegenMed Service Sector
The WuXi acquisition of Apptec (posted last week) is continuing the trend of consolidation in the cell manufacturing sector. It is similar to Lonza’s (a Swiss company) purchase of Cambrex’s biologics division in 2006, and GE’s purchase of Wave Biotech … Continue reading
Chinese CRO WuXi Pharmatech Acquires Apptec Laboratory Services
WuXi (pronounced Woo-See) Pharmatech, a contract research organization (CRO) based in China, announced the acquisition of MN-based Apptec Laboratory Services. WuXi acquired Apptec to gain an immediate US footprint, better access to the US market, and important biologics expertise to … Continue reading
The Regeneration Station 